5-Aza-2′-deoxycytidine restores the E-cadherin system in E-cadherin-silenced cancer cells and reduces cancer metastasis

Jeong Seok Nam, Yoshinori Ino, Yae Kanai, Michiie Sakamoto, Setsuo Hirohashi

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Down-regulation of the E-cadherin-mediated cell adhesion system is strongly related to cancer invasion and metastasis. Aberrant CpG hypermethylation in the promoter region of the E-cadherin gene has been shown to be responsible for reduction of E-cadherin expression. The present study was designed to test the hypothesis that the demethylating agent 5-aza-2′-deoxycytidine (AZA) can restore the E-cadherin system and reduce the potential for metastasis. AZA treatment modified the methylation status of the 5′ CpG island in the E-cadherin promoter, and induced re-expression of E-cadherin in human cancer cells whose E-cadherin expression had been silenced. The re-expressed E-cadherin was correlated with increased in vitro aggregation and reduced motility. After inoculation of cancer cells (MDA-MB-435S) into the mammary fat pads of mice with severe combined immunodeficiency, the mice were treated for nine consecutive weeks with AZA three times per week i.p. The AZA treatment suppressed both growth of the primary tumor and lung metastasis in comparison with untreated controls, suggesting that the suppression of metastasis may be, at least partly, attributable to restoration of E-cadherin expression. Therefore, inhibition of DNA methylation may be useful for preventing cancer metastasis.

Original languageEnglish
Pages (from-to)49-56
Number of pages8
JournalClinical and Experimental Metastasis
Volume21
Issue number1
DOIs
Publication statusPublished - 2004

Fingerprint

decitabine
Cadherins
Neoplasm Metastasis
Neoplasms
Severe Combined Immunodeficiency
CpG Islands
DNA Methylation

Keywords

  • 5-aza-2′-deoxycytidine
  • Aggregation
  • DNA methylation
  • E-cadherin
  • Metastasis
  • Motility

ASJC Scopus subject areas

  • Cancer Research

Cite this

5-Aza-2′-deoxycytidine restores the E-cadherin system in E-cadherin-silenced cancer cells and reduces cancer metastasis. / Nam, Jeong Seok; Ino, Yoshinori; Kanai, Yae; Sakamoto, Michiie; Hirohashi, Setsuo.

In: Clinical and Experimental Metastasis, Vol. 21, No. 1, 2004, p. 49-56.

Research output: Contribution to journalArticle

@article{9436e8c31f864edb96865dff8ff51773,
title = "5-Aza-2′-deoxycytidine restores the E-cadherin system in E-cadherin-silenced cancer cells and reduces cancer metastasis",
abstract = "Down-regulation of the E-cadherin-mediated cell adhesion system is strongly related to cancer invasion and metastasis. Aberrant CpG hypermethylation in the promoter region of the E-cadherin gene has been shown to be responsible for reduction of E-cadherin expression. The present study was designed to test the hypothesis that the demethylating agent 5-aza-2′-deoxycytidine (AZA) can restore the E-cadherin system and reduce the potential for metastasis. AZA treatment modified the methylation status of the 5′ CpG island in the E-cadherin promoter, and induced re-expression of E-cadherin in human cancer cells whose E-cadherin expression had been silenced. The re-expressed E-cadherin was correlated with increased in vitro aggregation and reduced motility. After inoculation of cancer cells (MDA-MB-435S) into the mammary fat pads of mice with severe combined immunodeficiency, the mice were treated for nine consecutive weeks with AZA three times per week i.p. The AZA treatment suppressed both growth of the primary tumor and lung metastasis in comparison with untreated controls, suggesting that the suppression of metastasis may be, at least partly, attributable to restoration of E-cadherin expression. Therefore, inhibition of DNA methylation may be useful for preventing cancer metastasis.",
keywords = "5-aza-2′-deoxycytidine, Aggregation, DNA methylation, E-cadherin, Metastasis, Motility",
author = "Nam, {Jeong Seok} and Yoshinori Ino and Yae Kanai and Michiie Sakamoto and Setsuo Hirohashi",
year = "2004",
doi = "10.1023/B:CLIN.0000017180.19881.c1",
language = "English",
volume = "21",
pages = "49--56",
journal = "Clinical and Experimental Metastasis",
issn = "0262-0898",
publisher = "Springer Netherlands",
number = "1",

}

TY - JOUR

T1 - 5-Aza-2′-deoxycytidine restores the E-cadherin system in E-cadherin-silenced cancer cells and reduces cancer metastasis

AU - Nam, Jeong Seok

AU - Ino, Yoshinori

AU - Kanai, Yae

AU - Sakamoto, Michiie

AU - Hirohashi, Setsuo

PY - 2004

Y1 - 2004

N2 - Down-regulation of the E-cadherin-mediated cell adhesion system is strongly related to cancer invasion and metastasis. Aberrant CpG hypermethylation in the promoter region of the E-cadherin gene has been shown to be responsible for reduction of E-cadherin expression. The present study was designed to test the hypothesis that the demethylating agent 5-aza-2′-deoxycytidine (AZA) can restore the E-cadherin system and reduce the potential for metastasis. AZA treatment modified the methylation status of the 5′ CpG island in the E-cadherin promoter, and induced re-expression of E-cadherin in human cancer cells whose E-cadherin expression had been silenced. The re-expressed E-cadherin was correlated with increased in vitro aggregation and reduced motility. After inoculation of cancer cells (MDA-MB-435S) into the mammary fat pads of mice with severe combined immunodeficiency, the mice were treated for nine consecutive weeks with AZA three times per week i.p. The AZA treatment suppressed both growth of the primary tumor and lung metastasis in comparison with untreated controls, suggesting that the suppression of metastasis may be, at least partly, attributable to restoration of E-cadherin expression. Therefore, inhibition of DNA methylation may be useful for preventing cancer metastasis.

AB - Down-regulation of the E-cadherin-mediated cell adhesion system is strongly related to cancer invasion and metastasis. Aberrant CpG hypermethylation in the promoter region of the E-cadherin gene has been shown to be responsible for reduction of E-cadherin expression. The present study was designed to test the hypothesis that the demethylating agent 5-aza-2′-deoxycytidine (AZA) can restore the E-cadherin system and reduce the potential for metastasis. AZA treatment modified the methylation status of the 5′ CpG island in the E-cadherin promoter, and induced re-expression of E-cadherin in human cancer cells whose E-cadherin expression had been silenced. The re-expressed E-cadherin was correlated with increased in vitro aggregation and reduced motility. After inoculation of cancer cells (MDA-MB-435S) into the mammary fat pads of mice with severe combined immunodeficiency, the mice were treated for nine consecutive weeks with AZA three times per week i.p. The AZA treatment suppressed both growth of the primary tumor and lung metastasis in comparison with untreated controls, suggesting that the suppression of metastasis may be, at least partly, attributable to restoration of E-cadherin expression. Therefore, inhibition of DNA methylation may be useful for preventing cancer metastasis.

KW - 5-aza-2′-deoxycytidine

KW - Aggregation

KW - DNA methylation

KW - E-cadherin

KW - Metastasis

KW - Motility

UR - http://www.scopus.com/inward/record.url?scp=1642289104&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642289104&partnerID=8YFLogxK

U2 - 10.1023/B:CLIN.0000017180.19881.c1

DO - 10.1023/B:CLIN.0000017180.19881.c1

M3 - Article

C2 - 15065602

AN - SCOPUS:1642289104

VL - 21

SP - 49

EP - 56

JO - Clinical and Experimental Metastasis

JF - Clinical and Experimental Metastasis

SN - 0262-0898

IS - 1

ER -